EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Collegium Pharmaceutical, Inc.
COLL

COLL Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc. · NASDAQ
Market Closed
22.75
▼ ⁦-0.74%⁩ (-0.17)
Market Cap$737.9M
Beta0.72
52w Low52w High
22.6450.79
Last Week
⁦-5.21%⁩
Last Month
⁦-36.35%⁩
Last 3 Months
⁦-32.45%⁩
Last Year
⁦-41.32%⁩
EL7 Factor Analysis
How we score this
Overall71
Strong — clearly above market medianContrarianF 6/9DistressBetter than 71% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
93
18.1x17.8xTop tier
▸
Growth
75
14.3%▲7.1%Top tier
▸
Quality
93
11.4%▲4.5%Top tier
▸
Safety
53
1.9x▲2.6xAround median
▸
Capital Return
24
—2.12%Bottom tier
▸
Momentum
10
-8.6%▼2.9%Bottom tier
▸
Sentiment
64
33Around median

Frequently Asked Questions

What is Collegium Pharmaceutical, Inc. stock?▼

Collegium Pharmaceutical, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.

How can I invest in Collegium Pharmaceutical, Inc.?▼

You can buy Collegium Pharmaceutical, Inc. shares through a licensed brokerage. Research the company's financials before investing.

What are the key metrics for evaluating Collegium Pharmaceutical, Inc.?▼

Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.

Does Collegium Pharmaceutical, Inc. pay dividends?▼

Dividend policies vary by company. Check the dividends section on the stock page for the payout history.

What are the risks of investing in Collegium Pharmaceutical, Inc.?▼

Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.

Fair Value
Low confidenceCurrent price$23
Analyst target · 1 analysts
$48
—
Range ⁦$45–$49⁩
vs
DCF (estimate)
$202
⁦+790%⁩
Sees it clearly undervalued
⁦7.9⁩% discount · ⁦5⁩% growth

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener

AI analysis from the earnings call, financials and news

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 1 analysts setting price target
$47.33
⁦+108.0%⁩
Current Price $22.75·Median $48.00
Low
$45.00
High
$49.00
Current price
$22.75
Average target
$47.33
Street summary

Negative revision of the price target for Collegium Pharmaceutical (COLL) stock

Bearish tilt

The price target for COLL stock has seen a notable decline of 18.1% over the past thirty days, as the analyst consensus dropped from $58 to $47.5. Despite this downward adjustment, the current price target ($47.5) and the lowest available estimate ($35) remain significantly higher than the current stock price of $27.2, indicating a valuation gap in favor of the stock despite the lowered expectations.

As of 2026-08-10
Revisions momentum · 30d
⁦-0.4%⁩
Average rating
★ 4.20
Buy
Analyst coverage
5
Buy conviction
80%
High
Target dispersion
18%
Analyst ratings over time5 analysts rating
2
2
1
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months4.17 → 4.20
Recent analyst moves
  • = Reiterate2026-02-10
    Truist Securities
    —· $58.00
  • = Reiterate2026-01-09
    Barclays
    —· $56.00
  • = Reiterate2026-01-09
    H.C. Wainwright
    Buy· $60.00
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    18.06x
    3.94x44.30x
    Cheap
  • Forward P/E
    2.88x
    4.64x37.16x
    Very cheap
  • EV / EBITDA
    3.76x
    3.77x30.13x
    Very cheap
  • FCF Yield
    44.3%
    -138.2%7.8%
    Exceptional
  • Revenue Growth YoY
    14.3%
    -56.9%93.8%
    Near median
  • EPS Growth YoY
    21.2%
    -160.1%130.2%
    Above average
  • Gross Margin
    60.0%
    12.8%90.7%
    Above average
  • ROIC
    11.4%
    -155.3%16.0%
    Strong
  • Net Debt / EBITDA
    1.86x
    0.60x5.10x
    Low debt
  • Dividend Yield
    —
    —
  • Payout Ratio
    —
    —
  • Altman Z-Score
    0.81
    -38.7417.53
    Strong
Financial Analysis
|